View by Specialty

Trending

Stomach
September 27, 2024
5 min read
Save

Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?

Neurology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
November 16, 2022
1 min read
Save

Offspring of mothers with preeclampsia have elevated risk for stroke, heart disease

Offspring of mothers with preeclampsia have elevated risk for stroke, heart disease

In a Scandinavian cohort, offspring born to mothers with preeclampsia had elevated risk for ischemic heart disease and stroke, researchers reported in JAMA Network Open.

SPONSORED CONTENT
November 15, 2022
2 min read
Save

Inebilizumab reduces B-cell subsets in neuromyelitis optica spectrum disorder attacks

Inebilizumab reduces B-cell subsets in neuromyelitis optica spectrum disorder attacks

Treatment with inebilizumab was associated with reduction in aquaporin-4 antibody titers and B cells for those with neuromyelitis optica spectrum disorder, according to an expert at ECTRIMS 2022.

Trending

Stomach
September 27, 2024
5 min read
Save

Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?

SPONSORED CONTENT
November 15, 2022
2 min read
Save

Q&A: When should benztropine be prescribed for patients with movement disorders?

Q&A: When should benztropine be prescribed for patients with movement disorders?

Neurocrine Biosciences Inc. recently presented data on comorbidities, polypharmacy and treatment patterns of patients prescribed benztropine who also were being treated with antipsychotic medications.

SPONSORED CONTENT
November 14, 2022
3 min read
Save

Osteopathic manipulation treatment 'very effective' for post-COVID-19 symptoms

Osteopathic manipulation treatment may be an effective treatment option for alleviating post-COVID symptoms, according to a speaker at the American Osteopathic Association’s OMED conference.

SPONSORED CONTENT
November 14, 2022
1 min read
Save

FDA accepts NDA for generalized myasthenia gravis treatment

FDA accepts NDA for generalized myasthenia gravis treatment

The FDA has accepted a new drug application for zilucoplan, an investigational treatment for generalized myasthenia gravis in adults who are acetylcholine receptor antibody positive, UCB announced in a released statement.

SPONSORED CONTENT
November 14, 2022
2 min read
Save

Alzheimer's treatment fails to meet primary endpoints in phase 3 trial

Alzheimer's treatment fails to meet primary endpoints in phase 3 trial

Gantenerumab, a treatment for mild cognitive impairment due to Alzheimer’s disease, did not meet the primary endpoint of slowing cognitive decline in a phase 3 clinical trial, Genentech announced in a released statement.

SPONSORED CONTENT
November 14, 2022
3 min read
Save

Set appropriate expectations for Treasury Inflation Protected Securities

Set appropriate expectations for Treasury Inflation Protected Securities

Treasury Inflation Protected Securities, aka TIPS, provide investors with a return that is indexed to inflation over the life of the bond. With the sharp increase in inflation that began in 2021, many investors who own TIPS expected to see gains as a result.

SPONSORED CONTENT
November 11, 2022
1 min read
Save

FDA accepts NDA for extended-release carbidopa/levodopa Parkinson’s treatment

FDA accepts NDA for extended-release carbidopa/levodopa Parkinson’s treatment

The FDA has accepted a new drug application from Amneal Pharmaceuticals Inc. for IPX203, an oral formulation of carbidopa/levodopa extended-release capsules for treatment of Parkinson’s disease, the company announced in a press release.

SPONSORED CONTENT
November 11, 2022
3 min read
Save

Oral ENT-01 improves constipation in patients with Parkinson’s disease

Oral ENT-01 improves constipation in patients with Parkinson’s disease

Oral ENT-01 treatment was safe and associated with improvements in constipation among patients with Parkinson’s disease, a study in Annals of Internal Medicine found.

SPONSORED CONTENT
November 11, 2022
1 min read
Save

AI-powered detection tool found 85% of aneurysms were not referred for follow-up

AI-powered detection tool found 85% of aneurysms were not referred for follow-up

Viz.ai has announced that 85% of aneurysms detected by Viz Aneurysm, its artificial intelligence-based detection tool, previously had not been referred for neurovascular review.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails